Investment adviser · CRD 283544

I.B.F. MANAGEMENT LTD.

Exempt reporting adviser (ERA)

Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.

REHOVOT, Israel · Form ADV filed Feb 4, 2026

Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →

Private funds & service providers

3 Private funds

The count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.

ISRAEL BIOTECH FUND II, L.P.Venture Capital Fund · Last reported Feb 4, 2026$25MGross asset value
Auditor KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED TEL AVIV, Israel
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED
PCAOB 1309

Fund details & source
Fund ID
805-8407432731
Reported beneficial owners
61
Minimum commitment
$25K
Form D file number
021-249881

Form ADV 2048892 · Feb 4, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ISRAEL BIOTECH FUND I, L.P.Venture Capital Fund · Last reported Feb 4, 2026$25MGross asset value

Form D fundraising filings

Israel Biotech Fund I, L.P.

Auditor KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED TEL AVIV, Israel
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED
PCAOB 1309

Fund details & source
Fund ID
805-3791898329
Reported beneficial owners
61
Minimum commitment
$25K
Form D file number
021-249881

Form ADV 2048892 · Feb 4, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ISRAEL BIOTECH FUND I, L.P.Venture Capital Fund · Last reported Feb 15, 2019$25MGross asset value
Auditor KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED TEL AVIV, Israel
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED
PCAOB 1309

Fund details & source
Fund ID
805-7967344161
Reported beneficial owners
61
Minimum commitment
$25K
Form D file number
021-249881

Form ADV 1272975 · Feb 15, 2019 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Services & filing details

Most recent filing: Feb 4, 2026. View historical filings

Reported services

Not reported in these imported fields

Compensation

Not reported in these imported fields

Principal office

4 OPPENHEIMER ST.
REHOVOT, 7670212, Israel

CRD 283544

Filing source

Form ADV 2048892 · Feb 4, 2026 · Items 1 & 5

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.